Heart failure & cardiomyopathiesCohort study
Rationale and Design of the ESC Heart Failure III Registry – Implementation and Discovery
- Registry design and rationale
- prospective registry
- multicentre
- international
Data on baseline characteristics, hospital course, diagnostic and therapeutic decisions, and outcomes at 12-month follow-up
Authors' conclusion
The ESC HF III Registry will provide comprehensive and unique insight into contemporary HF characteristics, treatment implementation, and outcomes, and may impact implementation strategies, clinical discovery, trial design, and public policy.
Study context
- Population
- Patients with chronic or acute/worsening HF with reduced, mildly reduced or preserved EF, 220 centres in 41 European or ESC affiliated countries, 1 November 2018–31 December 2020
- Participants
- 10,162 patients · 220 centres
Original publication
Rationale and Design of the ESC Heart Failure III Registry – Implementation and Discovery. Eur J Heart Fail. Published 29 November 2023. doi:10.1002/ejhf.3087
Summarised from the published abstract; every number is checked against it